معرفی
Shelley Amen is an Clinical Assistant Professor of Psychiatry at Yale University's Yale School of Medicine. She holds an MD (2011) and PhD (2009) from the Medical College of Wisconsin, and a BS in Psychology from Campbell University (2000).
Her research focuses on Post-Traumatic Stress Disorder (PTSD), particularly examining the effects of ketamine and neuroimaging-based treatments. Key areas include structural and functional neural changes post-treatment, and the role of white matter integrity in symptom improvement. Collaborations with researchers like Duek and Harpaz-Rotem highlight her work on long-term ketamine impacts and PTSD pathophysiology.
Publications emphasize translational research, bridging preclinical models (e.g., cocaine addiction in rodents) and clinical interventions (e.g., human craving reduction). While no explicit awards are noted, her contributions to PTSD and neuropsychopharmacology are evident through peer-reviewed publications in journals like Neuropsychopharmacology and Psychiatry Research Neuroimaging.
No grants or student advisement details are provided in the text, though her involvement in PTSD treatment studies and interdisciplinary collaborations underscores her role in advancing clinical and translational psychiatry.